Hepatocellular Carcinoma

CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]

AK112 is being studied in a Phase 1/Phase 2 trial for advanced hepatocellular carcinoma and is currently recruiting. The study is sponsored …

CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Pembrolizumab in Hepatocellular Carcinoma [Phase 2]

Pembrolizumab is being studied in a Phase 2 trial for hepatocellular carcinoma, and the study is currently active but not recruiting.

CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma

A ClinicalTrials.gov study led by the Chinese University of Hong Kong is investigating how radiotherapy affects circulating tumor DNA in pat…

CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis [Phase 2]

Phase 2 trial evaluating stereotactic body radiotherapy (SBRT) with immunotherapy and atezolizumab-bevacizumab in hepatocellular carcinoma w…

CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: THIO and Cadonilimab in Resectable Hepatocellular Carcinoma [EARLY_Phase 1]

An early-phase trial evaluating THIO in combination with Cadonilimab for resectable hepatocellular carcinoma. The study is not yet recruitin…

CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection

An update on a clinical trial evaluating safety and efficacy of transarterial Indocyanine Green fluorescence-guided laparoscopic liver resec…

CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]

This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across…

CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma [Phase 2, Phase 3]

Ongoing Phase 2/3 clinical study evaluating transarterial chemoembolization (TACE) with ABCB1 inhibition versus TACE alone for hepatocellula…

CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Ligufalimab and Cadonilimab in Advanced Liver Cancers [Phase 2]

Phase 2 clinical trial update on Ligufalimab and Cadonilimab in advanced hepatocellular carcinoma and biliary tract cancer, currently recrui…

CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment

A clinical trial update describing a study using 3D bioprinting to develop personalized treatments for hepatocellular carcinoma, with emphas…

CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

ClinicalTrials.gov lists a recruiting study evaluating whether emotional distress affects prognosis in patients with BCLC stage B/C hepatoce…

CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches

A clinical trial investigating epigenetic mechanisms driving immune evasion in hepatocellular carcinoma using omics approaches. The study is…

CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Liver Cancer Prevention Randomized Control Trial [NA]

This clinical trial update reports an active-not-recruiting randomized controlled trial aimed at preventing liver cancer. The study lists MD…

CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors [Phase 1, Phase 2]

A Phase 1/2 trial evaluating Q702, an oral Axl/Mer/CSF1R tyrosine kinase inhibitor, in combination with pembrolizumab, for selected advanced…

CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers [NA]

A pilot study comparing two ctDNA sampling methods (ctDNA IDV vs SPV) in patients undergoing biopsies for hepatobiliary and pancreatic cance…

CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma [Phase 2]

A Phase 2 trial evaluating checkpoint inhibitors for pediatric hepatocellular carcinoma, including fibrolamellar hepatocellular carcinoma, i…

CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers [NA]

Clinical trial evaluating early multigene sequencing for theranostics in advanced cancers to guide therapy, across breast cancer, hepatocell…

CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: SBRT With Atezo/Bev for HCC [Phase 1]

Phase 1 clinical trial evaluating the combination of SBRT (stereotactic body radiotherapy) with atezolizumab and bevacizumab for hepatocellu…

CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes [NA]

Cedars-Sinai Medical Center is recruiting for a study evaluating virtual reality to manage gastrointestinal cancer pain and improve patient-…

CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma [Phase 1]

A Phase 1 study at MD Anderson Cancer Center is using 18F-FS PG PET imaging to guide therapy for hepatocellular carcinoma. The trial is curr…